Navigation Links
PeriGen Knowledge Summit to Address Issues in Maternal Healthcare
Date:4/16/2010

Despite recent reports that show improved maternal healthcare worldwide, Amnesty International and The Lancet have found the standard of care dropping in the United States. PeriGen’s Knowledge Summit’s speakers will discuss why, and what can be done to correct this problem.

Washingtion, DC (Vocus) April 16, 2010 -- A new study in Lancet claims that maternal mortality rates around the world are going down. That should be good news in the debate over U.S. healthcare costs, except that the U.S. has an appalling record for maternal and infant mortality.

Amnesty International issued its own condemnation of U.S. maternity care, citing an infant mortality rate far above countries with fewer doctors, outdated technologies and primitive pre-natal care.

How can that be?
Come hear for yourself at the maternal-fetal medicine knowledge summit next Thursday, April 22 and Friday, April 23 at the Fairfax Embassy Row, 2100 Massachusetts Ave., N.W. The agenda for these meetings will address the maternal fetal medicine state of crisis: global and national maternity care; trends in healthcare information technology; and healthcare reform.

Did You Know?

 
  • Amnesty International’s March 2010 “Maternal Health Care Crisis in the USA” reports 34,000 American women have near-death experiences each year as they try to give birth.
  • The United States ranks 46th in infant mortality rate worldwide that’s below Cuba and just ahead of Croatia.
  • 30 percent of all births have incidents of difficulties that can lead to trauma
  • Studies show that 50 percent of avoidable medical errors are due to errors in cognition, and errors of communication.

WHO:   Nan Strauss, J.D. of Amnesty International will address global maternal-fetal morbidity and mortality rates, as well as clinical issues and trends and how the U.S. can improve its position as one of the lowest-ranked industrialized nations in terms of maternity care.
Dr. Peter Pronovost, an intensive care specialist and professor at Johns Hopkins Hospital and Johns Hopkins University School of Medicine. Dr. Pronovost is an internationally acclaimed leader in patient safety, whose ‘’checklist” concept dramatically reduced the rate of hospital-acquired infections after surgery.
Dr. Dan O’Keefe, Maternal-Fetal Medicine specialist, Chief Medical Officer for PeriGen

WHEN:   Thursday, April 22 and Friday, April 23, 2010

WHERE:   Fairfax Embassy Row
2100 Massachusetts Ave., N.W.
Washington, DC 20008

SPONSOR:   PeriGen

Anyone interested in attending should contact:

Brian Hegarty
Media Specialist

karma
230 south broad street, suite 1500
philadelphia, pennsylvania 19102

e brian(at)karmaverse(dot)com
p 215.790.7847 f 215.790.9751

###

Read the full story at http://www.prweb.com/releases/perigen/knowledge-summit/prweb3888134.htm.


'/>"/>
Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved

Related medicine news :

1. BusinessProcessGuidance.com Survey Exposes a Knowledge Worker Productivity Gap
2. Compass Knowledge Group and University of Illinois at Chicago to Co-Present at UCEA National Conference April 2010
3. New UCSF Global Health Initiative Will Help Bridge Gap Between Knowledge, Action
4. New global health initiative will help bridge gap between knowledge, action
5. Adritech Software Releases Website Realizer, a Website Builder to Create Websites without Any Programming Knowledge
6. Beware the Gentle Man With Unique Knowledge: The Passion and Skill of a Rising Star
7. American Heart Association Rapid Access Journal Report: Study Finds Racial Gaps Continue in Heart Disease Awareness, Low Knowledge of Heart Attack Warning Signs Among Women
8. Renowned Duke researcher wins Frontiers of Knowledge Award
9. Lefkowitz, BBVA Foundation Frontiers of Knowledge Award in Biomedicine
10. Firsthand Knowledge of E85 Earns Waconia Man a Free Trip to Soldier Field to See Monday Night Vikings-Bears Game
11. Projects In Knowledge(R) Is Brightening the Holidays for Many in Need
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... ... March 28, 2017 , ... WHO: , Dr. Paul ... , WHAT: , Medical doctors and PhD scientists will speak to the press on ... Trump in support of an independent vaccine safety commission. , WHERE: , Zenger ...
(Date:3/28/2017)... ... March 28, 2017 , ... The Radiology Business Management Association (RBMA) ... as its new executive director. Mr. Still was selected through a careful months-long search ... as he is known to our members, has been a part of building the ...
(Date:3/28/2017)... , ... March 28, 2017 , ... ... physicians, Paul Yost, will begin serving as new board chair for Orange County ... Yost will serve the remainder of soon-to-be former chair Mark Refowitz’s term, which ...
(Date:3/28/2017)... ... 28, 2017 , ... Neurotechnology , a provider of ... attendance tracking products: the new NCheck Cloud Bio Attendance cloud-based service and the ... face recognition to enable users to check in and out from anywhere via ...
(Date:3/28/2017)... MA (PRWEB) , ... March 28, 2017 , ... ... for direct measurement of corrosive ions found in power plant water and steam. ... components such as turbines and boilers, leading to extensive maintenance and unplanned shutdowns. ...
Breaking Medicine News(10 mins):
(Date:3/28/2017)... March 28, 2017  Orexigen Therapeutics, Inc. (Nasdaq: ... for the fourth quarter and year ended December 31, ... of transformational progress for Orexigen, beginning with the re-acquisition ... Commencing early March, the team at Orexigen demonstrated remarkable ... which reshaped and strengthened our Company while rewarding us ...
(Date:3/28/2017)... BOSTON , March 28, 2017  Market ... today announced a partnership with premium news content ... pharmaceutical companies to extract key insights from Dow ... mining technology. The Linguamatics I2E platform ... 20 global pharmaceutical companies. The Linguamatics-Dow Jones partnership ...
(Date:3/28/2017)... 28, 2017  AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), ... and commercialization of innovative therapies for the treatment ... Medicines Agency (EMA) has notified the company that ... Authorisation Application (MAA) has passed validation, and that ... The MAA for ARX-04 (known as DSUVIA™ in ...
Breaking Medicine Technology: